142 related articles for article (PubMed ID: 38520792)
1. Vitamin D status and neuromyelitis optica spectrum disease: A systematic review and meta-analysis.
Zhu Y; Cao S; Hu F; Zhou X; Xue Q
Clin Neurol Neurosurg; 2024 Apr; 239():108190. PubMed ID: 38520792
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D status and the risk of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.
Liu S; Tan B; Zhou J; Xiao L; Li M; Yin J
J Clin Neurosci; 2024 Jan; 119():185-192. PubMed ID: 38113581
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis.
Islam MA; Khandker SS; Alam SS; Kotyla P; Hassan R
Autoimmun Rev; 2019 Nov; 18(11):102392. PubMed ID: 31520805
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis.
Barzegar M; Mirmosayyeb O; Ebrahimi N; Bagherieh S; Afshari-Safavi A; Hosseinabadi AM; Shaygannejad V; Asgari N
Mult Scler Relat Disord; 2022 Jan; 57():103359. PubMed ID: 35158468
[TBL] [Abstract][Full Text] [Related]
6. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D
Cho EB; Shin JH; Kwon S; Kim J; Seok JM; Kim BJ; Min JH
Front Immunol; 2021; 12():677041. PubMed ID: 34394078
[TBL] [Abstract][Full Text] [Related]
7. Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.
Gao M; Yao X; Ding J; Hong R; Wu Y; Huang H; Zhuang L; Li Z; Wang Y; Zhang Y; Guan Y
J Clin Neurosci; 2019 Mar; 61():22-27. PubMed ID: 30692037
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Ma J; Yu H; Wang H; Zhang X; Feng K
J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
[TBL] [Abstract][Full Text] [Related]
9. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
Siritho S; Nopsopon T; Pongpirul K
J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of depression, anxiety, and sleep disturbances in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis.
Liu J; Zhang X; Zhong Y; Liu X
Mult Scler Relat Disord; 2023 Nov; 79():105007. PubMed ID: 37717305
[TBL] [Abstract][Full Text] [Related]
12. Serum Aquaporin 4-Immunoglobulin G Titer and Neuromyelitis Optica Spectrum Disorder Activity and Severity: A Systematic Review and Meta-Analysis.
Liu J; Tan G; Li B; Zhang J; Gao Y; Cao Y; Jia Z; Sugimoto K
Front Neurol; 2021; 12():746959. PubMed ID: 34744983
[No Abstract] [Full Text] [Related]
13. The Potential Immunoregulatory Roles of Vitamin D in Neuromyelitis Optica Spectrum Disorder.
Wu Y; Cai Y; Liu M; Zhu D; Guan Y
Mult Scler Relat Disord; 2020 Aug; 43():102156. PubMed ID: 32474282
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Immunosuppressive Drug Therapy for Neuromyelitis Optica Spectrum Disorders: An Overview of Meta-Analyses and Systematic Reviews.
Luo Y; Deng Y; Ran H; Yu L; Ma C; Zhao L; Li Y
Curr Neuropharmacol; 2023; 21(8):1827-1834. PubMed ID: 36154604
[TBL] [Abstract][Full Text] [Related]
15. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis.
Guan SY; Cai HY; Wang P; Lv TT; Liu LN; Mao YM; Zhao CN; Wu Q; Dan YL; Sam NB; Wang DG; Pan HF
Int J Rheum Dis; 2019 Oct; 22(10):1803-1813. PubMed ID: 31468723
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation reduces the risk of fall in the vitamin D deficient elderly: An updated meta-analysis.
Ling Y; Xu F; Xia X; Dai D; Xiong A; Sun R; Qiu L; Xie Z
Clin Nutr; 2021 Nov; 40(11):5531-5537. PubMed ID: 34656949
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis.
Moghadasi AN; Mirmosayyeb O; Mohammadi A; Sahraian MA; Ghajarzadeh M
Mult Scler Relat Disord; 2021 Apr; 49():102757. PubMed ID: 33486400
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review.
Naphattalung Y; Chuenkongkaew WL; Chirapapaisan N; Laowanapiban P; Sawangkul S
Ann Med; 2023 Dec; 55(1):2227422. PubMed ID: 37387119
[TBL] [Abstract][Full Text] [Related]
19. Systemic Connective Tissue Disease and Neuromyelitis Optica Spectrum Disorder Coexistence: A Systematic Review and Meta-Analysis.
Esposito JE; Annoni G; D'Amato M; Graziosi A; Troilo F; Di Risio A; Angelini G; Castiglione C; Tocco P; Volpe P; Di Iorio G; Parruti G; Polilli E
J Integr Neurosci; 2024 Feb; 23(2):35. PubMed ID: 38419451
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D level status in Thai neuromyelitis optica patients.
Jitprapaikulsan J; Siritho S; Prayoonwiwat N
J Neuroimmunol; 2016 Jun; 295-296():75-8. PubMed ID: 27235352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
